Mcgaughy Kent JR Buys Shares of Instil Bio, Inc. $TIL
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Mcgaughy Kent JR, insider at Instil Bio, Inc. ($TIL), bought 6,500 shares at an average price of $0. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Instil Bio, Inc. Stock Up 1.1%
Shares of Instil Bio, Inc. ($TIL) traded around $7.92 on Saturday, up 1.1% for the day.
Instil Bio, Inc. Earnings
Analysts Set New Price Targets
About Instil Bio, Inc.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Get Instil Bio, Inc. alerts
New 13F filings, insider trades, and analyst moves on $TIL, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.